Shiyang K. Gu
180 Fenglin Road
Zhongshan, China
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
The efficacy, safety, and rationale of orelabrutinib combined with obinutuzumab (O2) as a first-line systemic treatment for marginal zone lymphoma.
Journal: Blood cancer journal
Published: March 22, 2026
Long-term outcomes of autologous cell transplantation for patients with non-TAO autoimmune disease-related critical limb ischemia.
Journal: Cell transplantation
Published: March 03, 2026
Immune heterogeneity at diagnosis influences treatment response and survival in multiple myeloma.
Journal: Discover oncology
Published: November 05, 2025
Systematic profiling of single-, double- and triple-halogen substitution effects on the mononucleotide binding of N6-methyladenosine to human RNA m6A reader YTHDF1.
Journal: Nucleosides, nucleotides & nucleic acids
Published: October 15, 2025
Circulating Proteomic Panels for Noninvasive Diagnosis and Prognostication of Thromboangiitis Obliterans.
Journal: Journal of proteome research
Published: July 01, 2025
Purified CD34+ Cells Transplantation in Patients with Angiitis-Induced Chronic Limb-Threatening Ischemia: A Single-Center Retrospective Study over a 10-Year Period.
Journal: Annals of vascular surgery
Published: April 06, 2024
The role of proliferating stem-like plasma cells in relapsed or refractory multiple myeloma: Insights from single-cell RNA sequencing and proteomic analysis.
Journal: British journal of haematology
Published: December 01, 2023
A prognostic model incorporating inflammatory cells and cytokines for newly diagnosed multiple myeloma patients.
Journal: Clinical and experimental medicine
Published: October 23, 2022
Radiotherapy Advances in Renal Disease-Focus on Renal Ischemic Preconditioning.
Journal: Bioengineering (Basel, Switzerland)
Published: September 25, 2022
The peripheral blood mononuclear cells versus purified CD34+ cells transplantation in patients with angiitis-induced critical limb ischemia trial: 5-year outcomes and return to work analysis-a randomized single-blinded non-inferiority trial.
Journal: Stem cell research & therapy
Published: February 07, 2022
Autologous Stem Cells Transplantation for No-Option Angiitis-Induced Critical Limb Ischemia: Recurrence and New Lesion.
Journal: Stem cells translational medicine
Published: November 05, 2021
Last Updated: 09/26/2026